109 related articles for article (PubMed ID: 29498405)
81.
Miyoshi N; Yamamoto H; Mimori K; Yamashita S; Miyazaki S; Nakagawa S; Ishii H; Noura S; Ohue M; Yano M; Doki Y; Mori M
Oncol Lett; 2014 Nov; 8(5):2313-2317. PubMed ID: 25289111
[TBL] [Abstract][Full Text] [Related]
82. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target.
Chauhan S; Sen S; Irshad K; Kashyap S; Pushker N; Meel R; Sharma MC
Hum Cell; 2024 Jan; 37(1):297-309. PubMed ID: 37914903
[TBL] [Abstract][Full Text] [Related]
83. An intuitionistic approach for the predictability of anti-angiogenic inhibitors in cancer diagnosis.
Ansar SA; Aggarwal S; Arya S; Haq MA; Mittal V; Gared F
Sci Rep; 2023 Apr; 13(1):7051. PubMed ID: 37120640
[TBL] [Abstract][Full Text] [Related]
84. The Novel IGF-1R Inhibitor PB-020 Acts Synergistically with Anti-PD-1 and Mebendazole against Colorectal Cancer.
Kang B; Zhang X; Wang W; She S; Chen W; Chen C; Wang Y; Pan X; Xu O; Wang Y
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497233
[TBL] [Abstract][Full Text] [Related]
85. Development and Validation of a Combined Ferroptosis and Immune Prognostic Model for Melanoma.
Tang M; Li Y; Wang F; Han J; Gao Y
J Oncol; 2022; 2022():1840361. PubMed ID: 36467505
[TBL] [Abstract][Full Text] [Related]
86. Association between germline variants and somatic mutations in colorectal cancer.
Barfield R; Qu C; Steinfelder RS; Zeng C; Harrison TA; Brezina S; Buchanan DD; Campbell PT; Casey G; Gallinger S; Giannakis M; Gruber SB; Gsur A; Hsu L; Huyghe JR; Moreno V; Newcomb PA; Ogino S; Phipps AI; Slattery ML; Thibodeau SN; Trinh QM; Toland AE; Hudson TJ; Sun W; Zaidi SH; Peters U
Sci Rep; 2022 Jun; 12(1):10207. PubMed ID: 35715570
[TBL] [Abstract][Full Text] [Related]
87. The Relationship of Clinicopathological Findings and PDGFR-β Expression With Tumor Recurrence in Gastrointestinal Stromal Tumors.
Kaymaz E; Taşdöven İ; Barut F
Turk J Gastroenterol; 2021 Dec; 32(12):1038-1048. PubMed ID: 34876394
[TBL] [Abstract][Full Text] [Related]
88. P68 RNA Helicase facilitates Breast Cancer progression by promoting Proliferation and Migration via PDGFR-β/AR axis.
Panchbhai N; Turaga RC; Sharma M; Satyanarayana G; Liu ZR
J Cancer; 2021; 12(21):6543-6552. PubMed ID: 34659545
[TBL] [Abstract][Full Text] [Related]
89. Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.
Bownes LV; Williams AP; Marayati R; Quinn CH; Hutchins SC; Stewart JE; Vu T; Easlick JL; Mroczek-Musulman E; Crossman DK; Anderson JC; Willey CD; Datta PK; Beierle EA
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206917
[No Abstract] [Full Text] [Related]
90. Development of Radiogallium-Labeled Peptides for Platelet-Derived Growth Factor Receptor
Effendi N; Mishiro K; Shiba K; Kinuya S; Ogawa K
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374773
[TBL] [Abstract][Full Text] [Related]
91. Identifying metastasis-initiating miRNA-target regulations of colorectal cancer from expressional changes in primary tumors.
Lee J; Hong HK; Peng SB; Kim TW; Lee WY; Yun SH; Kim HC; Liu J; Ebert PJ; Aggarwal A; Jung S; Cho YB
Sci Rep; 2020 Sep; 10(1):14919. PubMed ID: 32913235
[TBL] [Abstract][Full Text] [Related]
92. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
[TBL] [Abstract][Full Text] [Related]
93. PAI1 is a Marker of Bad Prognosis in Rectal Cancer but Predicts a Better Response to Treatment with PIM Inhibitor AZD1208.
Muñoz-Galván S; Rivero M; Peinado-Serrano J; Martinez-Pérez J; Fernández-Fernández MC; Ortiz MJ; García-Heredia JM; Carnero A
Cells; 2020 Apr; 9(5):. PubMed ID: 32344898
[TBL] [Abstract][Full Text] [Related]
94. Targeted molecular profiling of genetic alterations in colorectal cancer using next-generation sequencing.
Luo J; Zhang S; Tan M; Li J; Xu H; Tan Y; Huang Y
Oncol Lett; 2020 Feb; 19(2):1137-1144. PubMed ID: 31966042
[TBL] [Abstract][Full Text] [Related]
95. Targeting Receptor Kinases in Colorectal Cancer.
García-Aranda M; Redondo M
Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30934752
[TBL] [Abstract][Full Text] [Related]
96. Targeted imaging and inhibition of triple-negative breast cancer metastases by a PDGFRβ aptamer.
Camorani S; Hill BS; Collina F; Gargiulo S; Napolitano M; Cantile M; Di Bonito M; Botti G; Fedele M; Zannetti A; Cerchia L
Theranostics; 2018; 8(18):5178-5199. PubMed ID: 30429893
[TBL] [Abstract][Full Text] [Related]
97. Platelet‑derived growth factor receptor‑β gene expression relates to recurrence in colorectal cancer.
Fujino S; Miyoshi N; Ohue M; Takahashi Y; Yasui M; Hata T; Matsuda C; Mizushima T; Doki Y; Mori M
Oncol Rep; 2018 May; 39(5):2178-2184. PubMed ID: 29498405
[TBL] [Abstract][Full Text] [Related]
98. Blockade of the PDGFR family together with SRC leads to diminished proliferation of colorectal cancer cells.
Kaulfuß S; Seemann H; Kampe R; Meyer J; Dressel R; König B; Scharf JG; Burfeind P
Oncotarget; 2013 Jul; 4(7):1037-49. PubMed ID: 23900414
[TBL] [Abstract][Full Text] [Related]
99. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
100. Antiproliferative effects of imatinib mesylate on ZR‑75‑1 and MDA‑MB‑231 cell lines via PDGFR‑β, PDGF‑BB, c‑Kit and SCF expression.
Kadivar A; Ibrahim Noordin M; Aditya A; Kamalidehghan B; Davoudi ET; Sedghi R; Akbari Javar H
Int J Mol Med; 2018 Jul; 42(1):414-424. PubMed ID: 29620139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
